QUOTED. Phil Brown.

The Medicines and Medical Devices Act presses the UK to create regulations that make the market attractive for business. But striking the right balance in creating the new agency is crucial, said Phil Brown, director of regulation and compliance for the Association of British HealthTech Industries.

Quoted Column

“The UK’s [technical requirements] should be at least the same as those of the EU, the US or other major world markets. There should be no place for a UK ‘light touch’ in this respect.” – Phil Brown, director of regulation and compliance, ABHI

Click here for a free trial of Medtech Insight

More from United Kingdom

More from Europe

Medtech Will Benefit From Boost To EU’s Quantum Technology Initiative

 

The European Commission is focusing on how tiny particles behave to help create an EU industrial “powerhouse.”

Burden Is Too Heavy For Medtechs To Go It Alone On Complex Medtech AI Projects

 

Medtech companies require expertise to navigate complex AI regulations and integrate AI in medical software while addressing regulatory challenges, claims expert AI consultant with medtech experience.

HealthAI: ‘Established Regulations Already Exist For Regulating AI In Healthcare Safely’

 

Paul Campbell, chief regulatory officer at HealthAI, emphasizes existing regulations for AI in healthcare should not be overlooked as new regulations are developed.